pharmacycanada-rxedtop

Daewoong Pharmaceutical announces Korea’s first-ever SGLT2 inhibitor for diabetes treatment

Daewoong Pharmaceutical’s enavogliflozin to demonstrate remarkable blood glucose lowering effect and favorable safety in type 2…